Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

AXL is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.

Axelrod HD, Valkenburg KC, Amend SR, Hicks JL, Parsana P, Torga G, De Marzo AM, Pienta KJ.

Mol Cancer Res. 2018 Oct 5. pii: molcanres.0718.2018. doi: 10.1158/1541-7786.MCR-18-0718. [Epub ahead of print]

PMID:
30291220
2.

Regarding the Congruence Between 2 Circulating Tumor DNA Sequencing Assays-Reply.

Torga G, Pienta KJ.

JAMA Oncol. 2018 Oct 1;4(10):1431-1432. doi: 10.1001/jamaoncol.2018.2326. No abstract available.

PMID:
30027215
3.

Ten unanswered questions in cancer: "If this is true, what does it imply"?

Amend SR, de Groot AE, Torga G, Axelrod HD, Reyes DK, Valkenburg KC, Glavaris SA, Pienta KJ.

Am J Clin Exp Urol. 2018 Apr 1;6(2):26-31. eCollection 2018. No abstract available.

4.

Cancer dormancy and criticality from a game theory perspective.

Wu A, Liao D, Kirilin V, Lin KC, Torga G, Qu J, Liu L, Sturm JC, Pienta K, Austin R.

Cancer Converg. 2018;2(1):1. doi: 10.1186/s41236-018-0008-0. Epub 2018 Jan 22.

5.

Epithelial and mesenchymal prostate cancer cell population dynamics on a complex drug landscape.

Lin KC, Torga G, Wu A, Rabinowitz JD, Murray WJ, Sturm JC, Pienta KJ, Austin R.

Converg Sci Phys Oncol. 2017 Dec;3(4). pii: 045001. Epub 2017 Aug 30.

6.

Patient-Paired Sample Congruence Between 2 Commercial Liquid Biopsy Tests.

Torga G, Pienta KJ.

JAMA Oncol. 2018 Jun 1;4(6):868-870. doi: 10.1001/jamaoncol.2017.4027. No abstract available.

PMID:
29242909
7.

Rare Renal Incidentaloma in Pregnancy: An Unusual Primitive Neuroectodermal Tumor Presentation.

Torga G, Barrow W, Han M.

Urol Case Rep. 2015 Jan 23;3(2):12-4. doi: 10.1016/j.eucr.2014.12.004. eCollection 2015 Mar.

8.

Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts.

Hernandez JR, Kim JJ, Verdone JE, Liu X, Torga G, Pienta KJ, Mooney SM.

Med Oncol. 2015 May;32(5):159. doi: 10.1007/s12032-015-0593-z. Epub 2015 Apr 9.

9.

Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells.

Shiraishi T, Verdone JE, Huang J, Kahlert UD, Hernandez JR, Torga G, Zarif JC, Epstein T, Gatenby R, McCartney A, Elisseeff JH, Mooney SM, An SS, Pienta KJ.

Oncotarget. 2015 Jan 1;6(1):130-43.

10.

The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptor.

Mooney SM, Parsana P, Hernandez JR, Liu X, Verdone JE, Torga G, Harberg CA, Pienta KJ.

J Cell Biochem. 2015 Jan;116(1):115-23. doi: 10.1002/jcb.24948.

Supplemental Content

Support Center